| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc. (ABEO) has 9 insiders with recent SEC Form 4 filings, including 5 buys and 6 sells. ABEO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.43M | $8.16M | - | |
| CFO | 587.2K | $3.35M | - | |
| VP | 464.7K | $2.65M | - | |
| Dir | 145.4K | $829.7K | - | |
| Dir | 139.1K | $793.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2023 | Silverstein Christine Berni | Director | Sell | 6,330 | $3.91 | $24,721.18 | -6.7% | +28.5% | +49.7% | |
| Sep 27, 2023 | Seshadri Vishwas80 | Chief Executive Officer | Buy | 20,000 | $4.07 | $81,400.00 | +4.0% | +28.5% | +49.7% | |
| Sep 20, 2023 | Amoroso Michael71 | Director | Sell | 327 | $3.90 | $1,275.30 | -0.3% | +24.2% | +52.6% | |
| Sep 19, 2023 | Vazzano Joseph Walter75 | Chief Financial Officer | Buy | 3,000 | $3.82 | $11,458.32 | +0.6% | +24.0% | +43.8% | |
| Sep 18, 2023 | O'Malley Brendan M.85 | SVP, General Counsel | Buy | 3,000 | $3.80 | $11,400.00 | +1.6% | +28.1% | +48.8% | |
| Jun 20, 2023 | Amoroso Michael71 | Director | Sell | 338 | $4.45 | $1,504.10 | -0.3% | -19.3% | -0.7% | |
| Apr 25, 2023 | Alvino Mark51 | Director | Sell | 887 | $3.25 | $2,882.75 | -4.8% | +10.4% | -2.8% | |
| Mar 20, 2023 | Amoroso Michael71 | Director | Sell | 268 | $2.33 | $624.44 | -0.5% | +97.8% | +229.1% | |
| Mar 3, 2023 | Amoroso Michael71 | Director | Sell | 1,002 | $2.38 | $2,384.76 | -1.7% | +20.9% | +208.7% | |
| Dec 9, 2022 | O'Malley Brendan M.85 | SVP, General Counsel | Buy | 5,869 | $3.13 | $18,369.97 | +6.7% | -8.3% | +53.2% |